Single TFs have also been successful in reprogramming glioma cells into neurons, with lentiviral introduction of Neurog2 demonstrating successful reprogramming of human glioma cells into neuron-like cells and decreased glioma growth with improved survival of tumor-bearing mice [49]. The gene discussed is NEUROG2; the disease is central nervous system cancer.